Roger Sinclair Kirby
#145,125
Most Influential Person Now
Roger Sinclair Kirby's AcademicInfluence.com Rankings
Roger Sinclair Kirbymedical Degrees
Medical
#2717
World Rank
#3149
Historical Rank
Urology
#20
World Rank
#21
Historical Rank
Roger Sinclair Kirbyphilosophy Degrees
Philosophy
#7776
World Rank
#11031
Historical Rank
Logic
#4813
World Rank
#6142
Historical Rank
Download Badge
Medical Philosophy
Why Is Roger Sinclair Kirby Influential?
(Suggest an Edit or Addition)Roger Sinclair Kirby's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- [Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging.male (MSAM-7)]. (2003) (918)
- Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in treatment of symptomatic benign prostatic hyperplasia: the Prospective European Doxazosin and Combination Therapy (PREDICT) trial. (2003) (366)
- Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). (2003) (281)
- WHAT IS THE ROLE OF INFLAMMATION IN THE PATHOGENESIS OF PROSTATE CANCER? (2007) (273)
- Intra-prostatic urinary reflux: an aetiological factor in abacterial prostatitis. (1982) (240)
- Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) – focus on the UK (2015) (206)
- Prazosin in the treatment of prostatic obstruction. A placebo-controlled study. (1987) (186)
- A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment. (2019) (167)
- Safety and Tolerability of the Dual 5α-Reductase Inhibitor Dutasteride in the Treatment of Benign Prostatic Hyperplasia (2003) (164)
- The natural history of benign prostatic hyperplasia: what have we learned in the last decade? (2000) (146)
- Textbook of Erectile Dysfunction (1999) (142)
- Nitrogen containing bisphosphonates induce apoptosis and inhibit the mevalonate pathway, impairing Ras membrane localization in prostate cancer cells. (2003) (141)
- The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators. (2000) (131)
- Guidelines for the diagnosis and treatment of benign prostatic hyperplasia: a comparative, international overview. (2001) (131)
- A multicenter, randomized, prospective study of endoscopic laser ablation versus transurethral resection of the prostate. (1995) (127)
- Zoledronic acid induces apoptosis and inhibits adhesion to mineralized matrix in prostate cancer cells via inhibition of protein prenylation (2004) (123)
- The risk of prostate cancer amongst black men in the United Kingdom: the PROCESS cohort study. (2007) (120)
- The effect of age on the autonomic innervation of the urinary bladder. (1986) (119)
- A combined analysis of double‐blind trials of the efficacy and tolerability of doxazosin‐gastrointestinal therapeutic system, doxazosin standard and placebo in patients with benign prostatic hyperplasia (2001) (108)
- Relationship between glutathione S-transferase M1, P1 and T1 polymorphisms and early onset prostate cancer. (2001) (98)
- Textbook of benign prostatic hyperplasia (1996) (91)
- Bladder neck contracture after radical retropubic prostatectomy (2004) (91)
- Infection after transrectal ultrasonography‐guided prostate biopsy: increased relative risks after recent international travel or antibiotic use (2012) (90)
- Management of acute urinary retention (2006) (90)
- Immunotherapy of advanced prostate cancer: a phase I/II trial using Mycobacterium vaccae (SRL172). (1998) (87)
- Selectivity of finasteride as an in vivo inhibitor of 5alpha-reductase isozyme enzymatic activity in the human prostate. (1999) (84)
- Guideline for the primary care management of male lower urinary tract symptoms (2004) (83)
- The Risk of Prostate Cancer amongst Black Men in the United Kingdom: The PROCESS Cohort Study (2008) (82)
- Endometriosis of the ureter. (1992) (82)
- Ki-67 expression in early prostate cancer and associated pathological lesions. (1996) (79)
- Prospective observational study to assess value of prostate specific antigen as screening test for prostate cancer (1995) (75)
- The management of intractable haematuria (2000) (74)
- A three month double‐blind study of doxazosin as treatment for benign prostatic bladder outlet obstruction (1994) (73)
- The day-to-day variation (test-retest reliability) of residual urine measurement. (1996) (73)
- Doxazosin in benign prostatic hyperplasia: effects on blood pressure and urinary flow in normotensive and hypertensive men. (1995) (70)
- Prostate specific antigen and bone scan correlation in the staging and monitoring of patients with prostatic cancer. (1992) (65)
- A three month double-blind study of doxazosin as treatment for benign prostatic bladder outlet obstruction. (1994) (64)
- A randomized, double‐blind crossover study of tamsulosin and controlled‐release doxazosin in patients with benign prostatic hyperplasia (2003) (64)
- Alpha adrenoceptor blockade in the treatment of benign prostatic hyperplasia: past, present and future. (1997) (59)
- Acute urinary retention: what is the impact on patients’ quality of life? (2005) (57)
- Evaluation and Nonsurgical Management of Benign Prostatic Hyperplasia (2012) (57)
- Improving outcomes in Fournier's gangrene (2004) (56)
- Francois de LaPeyronie (1978-1747): the man and the disease he described. (1996) (56)
- 5 Alpha-reductase inhibitors: what's new? (2003) (53)
- The international terazosin trial: a multicentre study of the long-term efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia. The ITT Group. (1996) (53)
- Benign prostatic hyperplasia: effects on quality of life and impact on treatment decisions. (1994) (52)
- Fortnightly Review: Impotence: diagnosis and management of male erectile dysfunction (1994) (52)
- Use of the ASI titanium stent in the management of bladder outflow obstruction due to benign prostatic hyperplasia. (1992) (49)
- Safety and tolerability of the dual 5alpha-reductase inhibitor dutasteride in the treatment of benign prostatic hyperplasia. (2003) (49)
- Repeated pressure‐flow studies in the evaluation of bladder outlet obstruction due to benign prostatic enlargement (1999) (48)
- The current status of robot-assisted radical prostatectomy. (2009) (48)
- Prostate cancer diagnosis in the new millennium: strengths and weaknesses of prostate‐specific antigen and the discovery and clinical evaluation of prostate cancer gene 3 (PCA3) (2009) (47)
- Efficacy of extended‐release doxazosin and doxazosin standard in patients with concomitant benign prostatic hyperplasia and sexual dysfunction (2005) (47)
- Acute Urinary Retention: a review of the aetiology and management (2004) (46)
- p21WAF1/CIP1 gene is inactivated in metastatic prostatic cancer cell lines by promoter methylation (2005) (45)
- Finasteride in the treatment of benign prostatic hyperplasia. A urodynamic evaluation. (1992) (45)
- BENIGN PROSTATIC HYPERPLASIA: COUNTING THE COST OF ITS MANAGEMENT (2010) (44)
- Treatment options for early prostate cancer. (1998) (44)
- Awareness of prostate cancer among the general public: findings of an independent international survey. (2003) (43)
- Is there a link between BPH and prostate cancer? (2012) (43)
- Terazosin in benign prostatic hyperplasia: effects on blood pressure in normotensive and hypertensive men. (1998) (42)
- Reproducibility of uroflow measurement: experience during a double-blind, placebo-controlled study of doxazosin in benign prostatic hyperplasia. (1996) (42)
- Imaging prostate cancer with technetium-99m-7E11-C5.3 (CYT-351). (1997) (41)
- Immunohistochemical expression of BRCA2 protein and allelic loss at the BRCA2 locus in prostate cancer (1998) (41)
- Association between the GCG polymorphism of the selenium dependent GPX1 gene and the risk of young onset prostate cancer (2002) (41)
- Finasteride in association with either flutamide or goserelin as combination hormonal therapy in patients with stage M1 carcinoma of the prostate gland (1999) (40)
- Nerve-sparing radical retropubic prostatectomy: techniques and clinical considerations (2005) (40)
- Utility of tissue microarrays for profiling prognostic biomarkers in clinically localized prostate cancer: the expression of BCL-2, E-cadherin, Ki-67 and p53 as predictors of biochemical failure after radical prostatectomy with nested control for clinical and pathological risk factors. (2009) (39)
- Balloon dilatation of the prostate. (1989) (39)
- Long-term urodynamic effects of finasteride in benign prostatic hyperplasia: a pilot study. (1993) (37)
- Encrustation of intraprostatic stents--a comparative study. (1992) (37)
- Prazosin in the Treatment of Prostatic Obstruction: A Placebo-Controlled Study (1989) (36)
- A selected review and personal experience with robotic prostatectomy: implications for adoption of this new technology in the United Kingdom (2007) (36)
- Diabetes and the urologist: a growing problem (2007) (36)
- Female pseudohermaphroditism due to a maternal adrenocortical tumor. (1990) (35)
- The prostatron transurethral microwave device in the treatment of bladder outflow obstruction due to benign prostatic hyperplasia. (1993) (35)
- Assessment of the results of Stamey bladder neck suspension. (1989) (35)
- Successful salvage robotic-assisted radical prostatectomy after external beam radiotherapy failure. (2008) (35)
- Venous leak surgery: long-term follow-up of patients undergoing excision and ligation of the deep dorsal vein of the penis. (1995) (34)
- Does endoscopic laser ablation of the prostate stand the test of time? Five‐year results from a multicentre randomized controlled trial of endoscopic laser ablation against transurethral resection of the prostate (2000) (34)
- RESULTS OF THE PREDICT (PROSPECTIVE EUROPEAN DOXAZOSIN AND COMBINATION THERAPY) TRIAL (1999) (33)
- Oat cell carcinoma of urinary bladder. (1992) (32)
- Accuracy and cost of intraoperative lymph node frozen sections at radical prostatectomy. (1999) (32)
- A review of radical prostatectomy from three centres in the UK: clinical presentation and outcome. (1996) (32)
- The effect of surgical operation of moderate severity on thyroid function (1973) (30)
- The risk of prostate cancer amongst South Asian men in southern England: the PROCESS cohort study (2008) (30)
- Abarelix and other gonadotrophin‐releasing hormone antagonists in prostate cancer (2009) (30)
- Prostate cancer management: (1) an update on localised disease (2003) (29)
- Impotence: diagnosis and management of male erectile dysfunction. (1994) (29)
- Proerectile pharmacological prophylaxis following nerve-sparing radical prostatectomy (NSRP) (2004) (29)
- Screening for carcinoma of the prostate: a GP based study. (1994) (28)
- Beneficial effects of extended‐release doxazosin and doxazosin standard on sexual health (2006) (28)
- Avoidance and management of positive surgical margins before, during and after radical prostatectomy (2002) (28)
- Testosterone replacement therapy for late onset hypogonadism: what is the risk of inducing prostate cancer? (2006) (28)
- Association between leptin receptor gene polymorphisms and early‐onset prostate cancer (2003) (27)
- Clinical Uroselectivity of Alfuzosin in the Treatment of Benign Prostatic Hyperplasia (1998) (27)
- Optimising repeat prostate biopsy decisions and procedures (2012) (27)
- Adenocarcinoma occurring within a caecocystoplasty. (1985) (26)
- Overcoming the challenges of robot-assisted radical prostatectomy (2011) (25)
- Mycobacterium vaccae (SRL172): a potential immunological adjuvant evaluated in rat prostate cancer. (1998) (24)
- Benign prostatic hyperplasia and male lower urinary tract symptoms (LUTS). (2011) (24)
- RECOGNIZING AND MANAGING THE COMPLICATIONS OF PROSTATE BIOPSY (2011) (24)
- Prognostic markers in clinically localised prostate cancer. (1999) (24)
- Luts and male sexual dysfunction: The multi-national survey of the aging male (MSAM-7) (2003) (23)
- TRANSITION FROM OPEN TO ROBOTIC‐ASSISTED RADICAL PROSTATECTOMY (2008) (23)
- Diagnosis and management of early prostate cancer. Report of a British association of urological surgeons working party. (1999) (22)
- Clinical significance of α1-adrenoceptor selectivity in the management of benign prostatic hyperplasia (2004) (22)
- Outcomes of robotic assisted radical prostatectomy (2009) (22)
- Advances in the treatment of metastatic prostate cancer. (2013) (21)
- Clinical Pharmacology of α1-Adrenoceptor Antagonists (1999) (20)
- α1-Adrenoceptor selectivity and the treatment of benign prostatic hyperplasia and lower urinary tract symptoms (2000) (20)
- So much cost, such little progress. (2014) (19)
- INFECTIONS AFTER PROSTATE BIOPSY AND ANTIBIOTIC RESISTANCE (2008) (19)
- Prostatic intraepithelial neoplasia: a risk factor for prostate cancer. (2005) (19)
- Genetic prodrug activation therapy (GPAT) in two rat prostate models generates an immune bystander effect and can be monitored by magnetic resonance techniques (2001) (19)
- Efficacy of doxazosin in normotensive and hypertensive patients with benign prostatic hyperplasia. (1995) (18)
- New Perspectives in Prostate Cancer (1998) (18)
- Benign prostatic hyperplasia (1999) (18)
- Screening for prostate cancer (1994) (18)
- Is the scrotal testis normal in unilateral cryptorchidism? (1985) (18)
- Helping men to help themselves (2011) (18)
- Prostate cancer management: (2) an update on locally advanced and metastatic disease (2003) (18)
- Diagnosis and management of early prostate cancer. Report of a British Association of Urological Surgeons Working Party (1999) (18)
- Alpha-adrenoceptor inhibitors in the treatment of benign prostatic hyperplasia. (1989) (17)
- Awareness of prostate cancer among patients and the general public: results of an international survey (2009) (17)
- Allelic imbalance at 13q14.2 approximately q14.3 in localized prostate cancer is associated with early biochemical relapse. (2007) (17)
- Malignant changes in the prostate with ageing. (1998) (17)
- MENTORSHIP PROGRAMMES FOR LAPAROSCOPIC AND ROBOTIC UROLOGY (2011) (17)
- Pre‐biopsy 3‐Tesla MRI and targeted biopsy of the index prostate cancer: correlation with robot‐assisted radical prostatectomy (2017) (16)
- A double-blind placebo-controlled study evaluating the onset of action of doxazosin gastrointestinal therapeutic system in the treatment of benign prostatic hyperplasia. (2005) (16)
- Measurement of blood E2F3 mRNA in prostate cancer by quantitative RT-PCR: a preliminary study (2007) (16)
- Zonal biochemical and morphological characteristics in BPH. (1995) (16)
- Sphincter electromyography in patients after radical prostatectomy and cystoprostatectomy. (1992) (15)
- Allelic imbalance at 13q14.2∼q14.3 in localized prostate cancer is associated with early biochemical relapse (2007) (15)
- Fast Facts: Benign Prostatic Hyperplasia (1997) (15)
- The clinical assessment of benign prostatic hyperplasia. (1992) (15)
- PROSTATE‐SPECIFIC ANTIGEN TESTING IN HYPOGONADISM: IMPLICATIONS FOR THE SAFETY OF TESTOSTERONE‐REPLACEMENT THERAPY (2006) (15)
- Advances in the use of bisphosphonates in the prostate cancer setting (2004) (14)
- alpha(1)-Adrenoceptor selectivity and the treatment of benign prostatic hyperplasia and lower urinary tract symptoms. (2000) (14)
- Eosinophilic prostatitis and prostatic specific antigen. (1992) (14)
- Awareness of prostate cancer among patients and the general public: results of an international survey (2009) (14)
- Renal cell carcinoma presenting with orbital metastases. (1995) (13)
- Shared care between general practitioners and urologists in the management of benign prostatic hyperplasia: a survey of attitudes among clinicians. (1995) (13)
- SCREENING FOR PROSTATE CANCER: THE WAY AHEAD (2010) (13)
- Sexual Dysfunction Associated with the Management of Prostate Cancer (1998) (13)
- The role of PSA in detection and management of prostate cancer. (2016) (12)
- Prostatic radioimmunoscintigraphy: preliminary results using technetium-labelled monoclonal antibody, CYT-351. (1996) (12)
- Clinical ease of using doxazosin in BPH patients with and without hypertension (2005) (12)
- IS OBESITY A RISK FACTOR FOR PROSTATE CANCER? (2007) (12)
- Doxazosin controlled release vs tamsulosin in the management of benign prostatic hyperplasia: an efficacy analysis (2004) (12)
- The clinical assessment of benign prostatic hyperplasia (1992) (12)
- Penetrating injuries in children: Is there a message? (2002) (11)
- Effect of Doxazosin GITS on Blood Pressure in Hypertensive and Normotensive Patients: A Review of Hypertension and BPH Studies (2003) (11)
- Conservation of inflatable penile prosthesis during radical retropubic prostatectomy. (1997) (11)
- An atlas of prostatic diseases (1997) (10)
- Prostate disease: management options for the primary healthcare team. Report of a working party of the British Prostate Group. (1995) (10)
- Early rehabilitation of erectile function after nerve‐sparing radical prostatectomy: what is the evidence? (2004) (10)
- Detubularisation in cystoplasty: clinical review. (1991) (10)
- DO STATINS PROTECT AGAINST PROSTATE CANCER? (2006) (10)
- Are the days of transurethral resection of prostate for benign prostatic hyperplasia numbered? Urologists must grasp the future. (1994) (10)
- Radical prostatectomy or watchful waiting? (2003) (10)
- Globalization of surgical expertise without losing the human touch: utilising the network, old and new (2012) (10)
- The urologist as the advocate of men's health (2005) (10)
- Benign prostatic hyperplasia and male lower urinary tract symptoms. (2012) (10)
- Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array (2016) (9)
- Treatment modalities for localised prostate cancer (2012) (9)
- Balloon dilatation of the prostate--should it have a place in the urologist's armamentarium? (1993) (9)
- Fast Facts: Prostate Cancer (1996) (9)
- Oncological outcomes of robotic-assisted radical prostatectomy after more than 5 years (2014) (9)
- IMPACT OF PROSTATE SIZE ON RESPONSE TO MEDICAL THERAPY FOR BENIGN PROSTATIC HYPERPLASIA (BPH): RESULTS OF THE PREDICT TRIAL (1999) (9)
- Improving lower urinary tract symptoms in BPH. (2011) (9)
- Post-operative serial prostate-specific antigen and transrectal ultrasound for staging incidental carcinoma of the prostate. (1995) (9)
- The urologist as an advocate of men's health: 10 suggested steps toward helping patients achieve better overall health. (2005) (9)
- HYPOANDROGEN‐METABOLIC SYNDROME: A SIGNIFICANT ISSUE FOR MEN’S HEALTH (2006) (9)
- Diagnostic and surgical aspects of renal carcinoma with involvement of the inferior vena cava. (1991) (8)
- SUPPORTING THE SUPPORTER: HELPING THE PARTNER OF PATIENTS NEWLY DIAGNOSED WITH PROSTATE CANCER (2010) (8)
- Clinical significance of alpha1-adrenoceptor selectivity in the management of benign prostatic hyperplasia. (2001) (8)
- IMPROVED SURVIVAL PROSPECTS FOR PATIENTS WITH CASTRATION‐RESISTANT PROSTATE CANCER (2011) (8)
- Malakoplakia and carcinoma of the prostate. (1993) (8)
- WHAT ARE THE RISKS OF SECOND CANCER FORMATION AFTER RADIOTHERAPY TO THE PROSTATE? (2006) (8)
- Ejaculatory disorders are frequent and bothersome in ageing males with luts: A worldwide survey (MSAM-7) (2003) (8)
- Finasteride and doxazosin alone or in combination for the treatment of benign prostatic hyperplasia (2007) (8)
- Haematuria due to mucocele of the appendix. (1989) (8)
- [Doxazosin in the gastrointestinal therapeutic system (GITS) and doxazosin standard in patients with benign prostatic hyperplasia. Double-blind trial of efficacy and tolerability]. (2000) (7)
- Does the nonurologic scientific community understand urothelial bladder cancer? (2014) (7)
- Medical therapy for benign prostatic hyperplasia: the road ahead. (1997) (7)
- Multifocal bilateral oncocytomas. (1993) (7)
- Combined scleroidal and choroidal metastasis from prostatic carcinoma. (1992) (7)
- Measurement of prostate specific antigen as screening test for prostate cancer (1996) (7)
- THE CASE OF THE BOILED BLADDER – OR, HOW TO AVOID MEDICAL ERRORS (2010) (7)
- DOES ROBOTICALLY ASSISTED RADICAL PROSTATECTOMY RESULT IN BETTER PRESERVATION OF ERECTILE FUNCTION? (2006) (7)
- CAN LIFESTYLE MODIFICATION LOWER THE RISK OF PROSTATE CANCER? (2009) (7)
- Treatment methods for early and advanced prostate cancer (2008) (7)
- Review: Modern treatment of erectile dysfunction (2002) (7)
- What is ‘survivorship’? (2013) (6)
- [Doxazosin GITS versus regular doxazosin in benign prostatic hyperplasia. Restoring urine flow and sexual function more easily]. (2000) (6)
- An update on the use of 5alpha-reductase inhibitors. (2004) (6)
- Steps by which better overall health for men could be achieved (2006) (6)
- Optimising the management of early prostate cancer. (2014) (6)
- How should we advise patients about the chemoprevention of prostate cancer? (2005) (6)
- The clinical role of α-blockers in the treatment of benign prostatic hyperplasia (2000) (6)
- Two‐drug therapy is best for symptomatic prostate enlargement: could a combination of doxazosin and finasteride change clinical practice? (2004) (6)
- LAPAROSCOPY OR ROBOTICS: WHERE DOES THE FUTURE LIE? (2009) (6)
- AVOIDING AND DEALING WITH THE COMPLICATIONS OF ROBOT‐ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (2010) (6)
- Prostate cancer treatment: the times they are a' changin' (2012) (6)
- Emotional intelligence and medicine (2016) (6)
- Daily phosphodiesterase type 5 inhibitor therapy: a new treatment option for prostatitis/prostatodynia? (2014) (6)
- Men's body image. (2009) (6)
- Urinary tract prostheses and their biocompatibility. (1993) (6)
- Intraprostatic stents--a new complication. (1992) (6)
- Radical Prostatectomy : From Open to Robotic (2007) (5)
- Choice at the end of life? (2018) (5)
- The Effect of Age on the Autonomic Innervation of the Urinary Bladder (1987) (5)
- Revisiting patient safety for innovative urological surgery (2012) (5)
- PCA3 improves diagnosis of prostate cancer. (2007) (5)
- IMPROVING PATIENT SAFETY IN UROLOGY (2010) (5)
- The European working‐time directive: one step forward, two steps back (2005) (5)
- Hepatitis B and C (2001) (5)
- Profile of doxazosin in the hypertensive man with benign prostatic hyperplasia. (1994) (5)
- An Atlas of Erectile Dysfunction (1999) (5)
- Supporting the ‘second victim’ after a medical error (2014) (5)
- Managing the complications of advanced prostate cancer (2008) (5)
- Changing paradigms in the investigation of an elevated PSA level (2013) (5)
- YOU CAN’T RESIST THE CHARMS OF THE ROBOT! (2010) (5)
- FACILITATING THE MEDICAL MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA IN PRIMARY CARE (2009) (4)
- Screening in general practice. (1995) (4)
- GETTING TO A BETTER “PLACE”: HELPING PATIENTS COUNTER OBESITY BY ACHIEVING ENDURING LIFESTYLE CHANGE (2011) (4)
- Wrong‐side/site surgery (2011) (4)
- Decision making in urological surgery (2012) (4)
- Cystectomy and substitution enterocystoplasty: alternative primary treatment for T2/3 bladder cancer. (1992) (4)
- GreenLight photoselective vaporisation of the prostate (2007) (4)
- Testosterone replacement therapy in hypogonadal men and prostate cancer risk (2005) (4)
- Abstracts: Poster session (1992) (4)
- HOW TO AVOID THE ‘SEVEN DEADLY SINS OF SURGERY’ (2012) (4)
- Obesity and men's health. (2004) (4)
- The perils of toxic masculinity: four case studies (2019) (4)
- Nephro-bronchial fistula. (1983) (4)
- The potential value of 5-alpha-reductase inhibition in the treatment of bladder outflow obstruction due to benign prostatic hyperplasia (1991) (4)
- Sexual Function: Quality of Life Issues in Patients with Locally Advanced Non-Metastatic Prostate Cancer (2002) (4)
- Prostate‐specific antigen testing for the early detection of prostate cancer (2004) (4)
- Voluntary screening program for HIV in pregnancy. Cost effectiveness. (2001) (4)
- THE UROLOGY FOUNDATION (TUF): WHERE HAVE WE COME FROM, WHERE ARE WE GOING? (2012) (4)
- Management of carcinoma of the prostate. (1999) (4)
- Advances in the use of bisphosphonates in the prostate cancer setting (2004) (4)
- Case study: management of advanced prostate cancer with soft tissue metastases (2005) (4)
- Increasing importance of truly informed consent: the role of written patient information (2013) (4)
- The importance of obtaining truly consensual informed consent (2012) (4)
- Doxazosin in the treatment of benign prostatic hyperplasia (2005) (4)
- Alpha-adrenoceptor blockers in the treatment of benign prostatic hyperplasia (1991) (3)
- PREVENTION AND MANAGEMENT OF HAEMATOMATA AFTER MINIMALLY INVASIVE RADICAL PROSTATECTOMY (2011) (3)
- First word (3)
- New developments in metastatic prostate cancer therapy. (2015) (3)
- Doxazosin in the treatment of benign prostatic hyperplasia. A review of the safety profile in older patients (1997) (3)
- Organ-Confined Prostate Cancer: Are We Moving Towards More or Less Radical Surgical Intervention? (2015) (3)
- Allelic imbalance and biochemical outcome after radical prostatectomy (2006) (3)
- Drug treatment in urology (2006) (3)
- Diagnosis of Lower Urinary Tract Symptoms Resulting from Benign Prostatic Hyperplasia (2012) (3)
- Management of clinically localized prostate cancer by radical prostatectomy followed by watchful waiting (2005) (3)
- Debates and controversies (2013) (3)
- Early detection the key to prostate cancer. (2009) (3)
- Men and cancer (epidemiology). (2009) (3)
- Coronavirus: reducing the impact of quarantine (2020) (3)
- The Prostate: Small Gland, Big Problem (2000) (3)
- Sir Henry Thompson: The first British Urologist (1820–1904) (1995) (3)
- Is premature ejaculation all in the mind? (2005) (3)
- The consequences of medical mistakes: the stakes are getting higher! (2014) (3)
- Meta‐analysis: creating a level playing field for the patient with symptomatic benign prostatic hyperplasia? (2004) (3)
- Hot Topics in Urology (2003) (3)
- Zoledronic acid: a new advance in managing skeletal events in prostate cancer (2003) (3)
- Doxazoxin : Safety relative to other medical therapies for benign prostatic hyperplasia (1996) (3)
- Clinical pharmacology of alpha1-adrenoceptor antagonists. (1999) (3)
- Prostate Cancer and Testosterone Replacement Therapy--What is the Risk? (2015) (3)
- Anatomy and physiology of the prostate and benign prostatic hyperplasia (2002) (2)
- Surgical reinforcement of gender identity in adolescent intersex patients. (1992) (2)
- Isolated ileal loop augmentation of existing ileal conduit. (1983) (2)
- PATIENT PERCEPTIONS OF THE EFFECT OF MEDICAL THERAPY FOR BENIGN PROSTATIC HYPERTROPHY (BPH) IN THE PREDICT TRIAL (1999) (2)
- Prostate cancer: lessons to be learned from breast cancer (2015) (2)
- Role of alpha1-adrenoceptors in the future treatment of urological diseases. (1999) (2)
- PROSTATE‐SPECIFIC ANTIGEN KINETICS AND THE DIAGNOSIS AND MANAGEMENT OF PROSTATE CANCER (2006) (2)
- Thyroid function after injury. (1972) (2)
- Tri-radiate incision approach for renal carcinoma invading the thoracic inferior vena cava. (1993) (2)
- Supporting the supporter: helping the partner of patients newly diagnosed with prostate cancer (2012) (2)
- PCA3 and Other Urinary Markers (2013) (2)
- Role of α1-Adrenoceptors in the Future Treatment of Urological Diseases (1999) (2)
- CARDIOVASCULAR RISK AND THE UROLOGICAL PATIENT (2009) (2)
- Benign prostatic hyperplasia: solutions to an ageing problem. (2002) (2)
- Chapter 11 – Genetic Changes and Their Prognostic Significance in Prostate Cancer (2003) (2)
- ABC of Prostate Cancer (2011) (2)
- Recent advances in urology (1998) (2)
- Basic assessment of the patient with erectile dysfunction (2008) (2)
- MORE PRO‐ACTIVITY IS REQUIRED IN THE BATTLE AGAINST OBESITY IN MEN (2009) (2)
- Men as risk takers. (2009) (2)
- Men and cancer (2009) (2)
- A tale of four prostates (2013) (2)
- Panel VIII: Surgical treatment for benign prostatic hyperplasia (1992) (2)
- The future management of prostate cancer? (1996) (2)
- Papaverine, benzodiazepines, and prolonged erections (1991) (2)
- 2. Prostatic radioimmunoscintigraphy: preliminary results (1994) (2)
- Lifestyle and the Urologist (2007) (2)
- Cancer of the prostate gland (2006) (2)
- Current status of choline‐PET and prostate cancer (2014) (2)
- Screening for Early Prostate Cancer (1996) (2)
- THE ROLE OF BOTULINUM TOXIN IN BENIGN PROSTATIC HYPERPLASIA (2006) (2)
- Current prospects for the chemoprevention of prostate cancer (2011) (1)
- Men's Health: Selecting long-term medical therapy for BPH (2004) (1)
- Editorial and introduction to Asian Journal of Andrology Prostate Cancer special issue. (2009) (1)
- Textbook of Erectile Dysfunction,Second Edition (2008) (1)
- Raised Prostate-Specific Antigen (2013) (1)
- Sequencing treatment for metastatic prostate cancer (2018) (1)
- Comparison of Robotic Laparoscopic and Open Radical Prostatectomy (2008) (1)
- Do prostate cancers in younger men have worse pathological characteristics in the PSA era (2003) (1)
- Men and the gastrointestinal system (2009) (1)
- Daily phosphodiesterase type 5 inhibitor therapy: a new treatment option for prostatitis/prostatodynia? (2015) (1)
- Advances in the diagnosis and treatment of prostate cancer. (2010) (1)
- Micron-scale characterization of magnesium-rich minerals in modern coralline algae: their compositions, crystal structures and spatial distribution (2016) (1)
- Active surveillance for men with low‐risk prostate cancer (2014) (1)
- ARE THE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDELINES THAT PROMULGATE ACTIVE SURVEILLANCE FOR LOW‐RISK PROSTATE CANCER JUSTIFIED BY THE AVAILABLE EVIDENCE? (2008) (1)
- The Challenge of Rising PSA. Can We Delay Prostate Cancer Progression?: AstraZeneca-Sponsored Satellite Symposium, EAU, Geneva, April 2001 (2001) (1)
- The Safe and Economical Care of Ta Bladder Cancer (2014) (1)
- Surgical Treatment of Prostate Cancer (2005) (1)
- The case of the boiled bladder – or, how to avoid medical errors (2010) (1)
- Maximal androgen blockade (MAB) for the treatment of prostate cancer (1996) (1)
- Comprar Treatment Methods for Early and Advanced Prostate Cancer | Roger S. Kirby | 9780415458931 | Informa Healthcare (2008) (1)
- When comes such another? (2014) (1)
- Diagnosis and management of bowel injury during laparoscopic surgery (2011) (1)
- An illustrated pocketbook of prostatic diseases (2002) (1)
- Alpha‐blockers in the treatment of benign prostatic hypertrophy (2013) (1)
- Kirby's Wonderful And Eccentric Museum (2011) (1)
- Radical prostatectomy vs watchful waiting (2005) (1)
- Poster Session 5: Prostate Cancer: Investigation (2003) (1)
- CURRENT PROSPECTS FOR THE CHEMOPREVENTION OF PROSTATE CANCER (2010) (1)
- Fact or fiction: What do the benign prostatic hyperplasia data tell us? (2005) (1)
- Dealing with the NHS staff recruitment and retention crisis (2020) (1)
- Revolution in prostate cancer treatment (2015) (1)
- Androgens and the androgen receptor in normal prostate (2005) (1)
- Men's Health, Third Edition (2009) (1)
- 347 A double-blind, placebo-controlled study to evaluate the onset of action of doxazosin gastrointestinal therapeutic system (GITS) in the treatment of BPH (soarx-early onset) (2004) (1)
- Faecal incontinence resulting from α1-adrenoceptor blockade (1990) (1)
- Controversies in Management: Urologists must grasp the future (1994) (1)
- Mechanisms of bisphosphonate induced apoptosis in prostate cancer (2002) (1)
- Management of BPH: role of the GP (2010) (1)
- Pharmacocavernometry in the Assessment of Erectile Impotence (1990) (1)
- Panel VII: Scope of the problem. Indications for treatment and assessment of benign prostatic hyperplasia and its relationship to cancer (1992) (1)
- ‘PROSTATE ACTION’ CHARITY CREATED BY MERGER OF PROSTATE UK AND PROSTATE CANCER RESEARCH FOUNDATION (2011) (1)
- Surgical treatment for benign prostatic hyperplasia. (1992) (1)
- Therapeutic treatment for benign prostatic hyperplasia (2005) (1)
- Prostate Cancer: Current Issues, New Approaches: International Congress, London, October 1995: Proceedings (1996) (1)
- Cardiac failure and benign prostatic hyperplasia: management of common comorbidities (2005) (1)
- Impotence: the radiologist's role. (1994) (1)
- Men and early prostate cancer (2018) (1)
- Management of patients with prostate cancer. (2006) (1)
- Prostate Cancer UK: the Blue Skies Forum (2013) (1)
- ACHIEVING EFFECTIVE RISK‐FACTOR MODIFICATION IN UROLOGICAL PATIENTS (2008) (1)
- Men and alcohol (2018) (1)
- Problem based urology (2013) (1)
- Current drug management of BPH in primary care (2006) (1)
- Surgeons and the ‘God complex’ (2017) (1)
- European patients with benign prostatic hyperplasia (BPH): Differences in sexual dysfunction (1997) (1)
- Dealing with the spiraling incidence of knife crime (2018) (1)
- Testosterone and the struggle for higher social status (2014) (1)
- The effect of surgical operation on thyroid activity. (1971) (1)
- Get ready for the genomic revolution (2017) (1)
- Urethroplasty for condylomata acuminata throughout the urethra. (1992) (1)
- Functional reconstruction of the urethra (1993) (1)
- The clinical role of alpha-blockers in the treatment of benign prostatic hyperplasia. (2000) (1)
- Anatomy and Pathophysiology of the Prostate Gland (1995) (1)
- Increasing importance of truly informed consent: the role of written patient information (2013) (1)
- Prostate Cancer (2021) (0)
- Siting factors for VORTAC:: part I (1962) (0)
- Treatment of locally advanced and metastatic prostate cancer (2008) (0)
- Alternative surgical treatments for obstructive BPH: balloons and stents. (1994) (0)
- STAGING INCIDENTAL CARCINOMA OF THE PROSTATE - REPLY (1995) (0)
- BUF in Sicily (2008) (0)
- Changes in IPSS at the end of the first 8 week efficacy period in a crossover study of doxazosin gits versus tamsulosin (2003) (0)
- A Christmas message (2014) (0)
- Diabetes mellitus: focus on type 2 diabetes. (2009) (0)
- Time to act: climate change and toxic air (2019) (0)
- Responding to the tsunami of clinical negligence claims (2018) (0)
- The British Urological Foundation goes from strength to strength (2007) (0)
- Reducing burnout amongst clinicians (2019) (0)
- Management of lower urinary tract symptoms due to BPH (2011) (0)
- LUTS, alpha‐blockers and men's health (2016) (0)
- General considerations affecting treatment options for patients with prostate cancer (2008) (0)
- ‘Survivorship’ in prostate cancer II: the need for ongoing patient support (2013) (0)
- Proceedings of PSA and prostatic disease conference, 21-22 May 1996, EURO/DPC Ltd, Llanberis, Wales (1997) (0)
- Editorial comment (2003) (0)
- Will the Olympics make us fitter or fatter? (2012) (0)
- Legends in Urology V30I02. (2023) (0)
- Manaqement of acute urinary retention (2006) (0)
- Cardiovascular risk reduction and men (2009) (0)
- Stepwise induction of prostatic neoplasia (2004) (0)
- Loin pain and a normal CT KUB: what to do? (2020) (0)
- UK Prostate charities merge (2012) (0)
- How to write a book (2001) (0)
- Peyronie’s disease: evaluation and review of non-surgical therapy Frederick L Taylor and Laurence A Levine (2008) (0)
- Hypertension and the role of the urologist (2005) (0)
- Radical prostatectomy vs watchful waiting. (2005) (0)
- Radical prostatectomy from three UK centres. (1997) (0)
- Winning the battle against obesity (2014) (0)
- Combination therapy to relieve storage symptoms (2015) (0)
- UP-REGULATION OF HYPOXIA-INDUCIBLE FACTOR 1α (HIF-1α) IS AN EARLY EVENT IN PROSTATE CANCER DEVELOPMENT (2006) (0)
- The NHS at 70 – where to next? (2018) (0)
- Seven years supporting men's health (2017) (0)
- Unsung heroes: Dr Thomas Stuttaford (2015) (0)
- Manslaughter and preventable harm (2015) (0)
- An interview with Roger Kirby, MA, MD, FRCS (Urol), FEBU (2012) (0)
- Treating the Whole Patient: BPH and Beyond: Symposium Held in Conjunction with the 3rd International Consultation of BPH, Monte Carlo, June 1995: Proceedings (1996) (0)
- The bane of lockdown loneliness (2021) (0)
- Potency-preserving surgery: radical prostatectomy and other pelvic surgery (2008) (0)
- Renal and urologyCancer of the prostate gland (2008) (0)
- First word (2010) (0)
- Radical prostatectomy from three UK centres [2] (1997) (0)
- To screen or not to screen? (2016) (0)
- All changed, changed utterly (2022) (0)
- Rising to the challenge (2012) (0)
- Men and chronic conditions (2009) (0)
- Prognostic markers for radical prostatectomy (1998) (0)
- First word: the trouble with men (2011) (0)
- Beware the Ebola virus, as well as obesity! (2014) (0)
- Personal Response System in Large Introductory Physics and Astronomy Classes (2005) (0)
- First word: turning back the rising tide of litigation (2011) (0)
- Fast Facts: Prostate Cancer, seventh edition (2011) (0)
- Panel Discussion II (1996) (0)
- Fact or fiction: What do the benign prostatic hyperplasia data tell us? (2005) (0)
- The use of cavity biopsies makes the assessment of margins safer after breast conserving surgery (2010) (0)
- Getting to a better ‘PLACE’ (2016) (0)
- Prostate cancer management: the times they are a‐changin' (2016) (0)
- Risk factors in men with erectile dysfunction. (2009) (0)
- Keeping fit: avoiding and diagnosing chronic soft-tissue injuries. (2009) (0)
- ‘Resilience’ – a characteristic clinicians now need to acquire (2016) (0)
- Men's Health (2021) (0)
- Prostate Cancer Screening: Can it Be Justified? (1997) (0)
- Tissue‐specific imaging of prostate cancer with 99Tcm‐labelled monoclonal antibody CYT‐351 (1995) (0)
- Comprar Textbook of Erectiel Dysfunction, Second Edition | Culley C. Carson III | 9781841846460 | Informa Healthcare (2008) (0)
- Management of lower urinary tract symptoms in BPH (2013) (0)
- ‘Survivorship’ in prostate cancer I: diagnostic and management considerations (2013) (0)
- Men's health down under (2012) (0)
- HIV infection and AIDS. (2009) (0)
- A 3-MONTH DOUBLE-BLIND STUDY OF DOXAZOSIN AS TREATMENT FOR BENIGN PROSTATEBLADDER OUTLET OBSTRUCTION. AUTHORS' REPLY (1995) (0)
- Is the NHS experiencing a workforce crisis? (2020) (0)
- Uroselectivity: myth or reality? Concluding remarks. (1998) (0)
- Treating the whole patient : BPH and beyond : proceedings of a symposium held in conjuction with the 3rd International Consultation on BPH, Monte Carlo, Monaco, June 26, 1995 (1996) (0)
- Selecting long-term medical therapy for BPH (2004) (0)
- Introduction (2001) (0)
- Dignity in dying (2015) (0)
- Autonomic failure and the role of the sympathetic nervous system in the control of lower urinary tract function. (1986) (0)
- Changes in presentation of prostate cancer in a non-screened population over five years (2003) (0)
- 2020 and the prospect of a ‘COVID Christmas’ (2020) (0)
- Screening for prostate cancer (1998) (0)
- There but for the grace of God (2014) (0)
- Renal and urology IIProstate cancer (2010) (0)
- Prevalence and correlates of serious injury among students of classes 7 and 8 in Kenya (2009) (0)
- Living in interesting times (2015) (0)
- Criminalisation of medical mistakes (2015) (0)
- The case for cutting back on red meat (2017) (0)
- Achieving effective risk‐factor modification in men (2011) (0)
- Whistleblowing (2019) (0)
- True or false? High-tech smoke detectors tackle false alarms. (1996) (0)
- Making a difference (0)
- Radical prostatectomy from three centres in the UK - Reply (1997) (0)
- Case study: management of lymph node-positive disease detected at radical prostatectomy (2005) (0)
- The problem with prison (2015) (0)
- Recent developments in laser therapy for BPH (2011) (0)
- Renal Conservation in the Management of Bilateral Renal Tumours (1992) (0)
- Improving the diagnosis and treatment of high‐risk localised or locally advanced prostate cancer (2015) (0)
- Concluding Remarks (1998) (0)
- ‘Toxic masculinity’: the problem with men (2019) (0)
- RAPID RESPONSE FROM BMJ.COM (2003) (0)
- Early detection the key to prostate cancer How is early disease managed ? (2010) (0)
- Medical Therapy for Benign Prostatic Hyperplasia (2008) (0)
- Taking the lead: success and leadership in medicine (2015) (0)
- The prevalence of prostatic intra-epithelial ncoplasia in biopsies from hospital practice and screening: Clinical and cost implications (1997) (0)
- Sexual health and men (2009) (0)
- 1 Anatomy and Pathophysiology of the Prostate Gland (0)
- Onwards and Upwards (2008) (0)
- When should patients with BPH be referred? (2008) (0)
- Introducing a new charity: Prostate Action (2010) (0)
- Raised blood pressure: the biggest cause of premature death and disability in men? (2009) (0)
- 56 Laterality of the fourth arm and impact on assistant input during robotic assisted laparoscopic prostatectomy: A comparative observational study (2010) (0)
- Value and cost of intra-operative lymph node frozen sections at radical prostatectomy hospital practice and screening: Clinical and cost implications (1997) (0)
- Locally advanced prostate cancer treated with radiotherapy and androgen deprivation (2005) (0)
- ONLY CONNECT (2009) (0)
- A tribute to urologist John Fitzpatrick, MCh (2014) (0)
- ‘Winter is coming’: a COVID‐19 wake‐up call (2020) (0)
- NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE GUIDELINE ON PROSTATE CANCER AND THE FUTURE OF CRYOTHERAPY (2009) (0)
- Succeeding as a hospital hoctor: The experts share their secrets (2007) (0)
- Localised prostate cancer: a case history-based look at the evidence. (2005) (0)
- Coronary heart disease in men. (2009) (0)
- 17. Prostate cancer radiommunoscintigraphy with 99Tcm-CYT‐351 against a prostate‐specific membrane antigen (1995) (0)
- Male preponderance of COVID‐19 risk (2020) (0)
- Ambulatory transurethral resection of the prostate (1994) (0)
- The management of hypertension in patients with benign prostatic hyperplasia and erectile dysfunction (2005) (0)
- Healthcare: ripe for disruption (2018) (0)
- Justice at last (2017) (0)
- Anatomy and Physiology of the Prostate and BPH (2005) (0)
- Why practical guidelines are required for managing BPH (2003) (0)
- Faecal incontinence resulting from alpha 1-adrenoceptor blockade. (1990) (0)
- Improving outcomes in uro‐oncology (2013) (0)
- Focal HIFU for prostate cancer. (2012) (0)
- Prostate cancer and testosterone replacement therapy: what is the risk? (2017) (0)
- BPH: when to rule out carcinoma of the prostate. (1994) (0)
- Panel Discussion (1964) (0)
- Taking care to avoid the ‘seven deadly sins of surgery’ (2015) (0)
- Combodart: combined therapy for moderate to severe BPH (2010) (0)
- The trouble with men (2013) (0)
- Thomas Stuttaford, 1931-2018 (2018) (0)
- M. Allelic imbalance and biochemical outcome after radical prostatectomy (2006) (0)
- Molecular diagnosis and staging of prostate cancer using clusterin in real time reverse transcription polymerase chain reaction (RT-PCR) (2006) (0)
- Exercise and men's health. (2004) (0)
- Clinico-pathological findings simulating prostatic malignancy following sclerotherapy: a diagnostic pitfall. (1996) (0)
- Perception of benign prostatic hyperplasia (BPH): Cultural differences in symptoms and impact (1997) (0)
- Cancer Times (2021) (0)
- Robotic Reconstruction Techniques Following Cystectomy (2012) (0)
- Men and mental/emotional health and trauma (2009) (0)
- Authors' reply (1996) (0)
- Getting to a better ‘PLACE’: helping patients counter obesity by achieving enduring lifestyle change (2011) (0)
- Unravelling the confusions in prostatic disease (1998) (0)
- Both sides now (2013) (0)
- Burnout, resilience and culture change (2017) (0)
- Prostate Cancer: Current Issues, New Approaches. Proceedings of an international congress. London, England, October 19-21, 1995. (1996) (0)
- Improving the surgical treatment of high‐risk localised or locally advanced prostate cancer (2015) (0)
- Clinical trial design for erectile dysfunction (2008) (0)
- Should patient assisted dying be legalised? (2019) (0)
- Clinical gynaecological urology. Asmussen and Miller. 280 × 220 mm. Pp. 207 + xiii. Illustrated. 1983. Oxford: Blackwell Scientific. £29.50 (1984) (0)
- Changes and challenges: a career in prostate surgery. (2013) (0)
- Topical agents for the treatment of premature ejaculation (2008) (0)
- UK PROSTATE CHARITIES MERGE (2012) (0)
- Sepsis: an important treatable illness, but susceptible to hype (2021) (0)
- Uroselectivity: Myth or Reality?: Satellite Symposium held during the 4th International Consultation on BPH, Paris, July 1997 (1998) (0)
- Heart attack! (2014) (0)
- Developing an effective vaccine for COVID‐19 (2020) (0)
- Contents Volume 33, No. 3, Section One (2004) (0)
- Professor John Betteridge, 1948–2019 (2020) (0)
- Managing locally advanced prostate cancer: a urologist's and a patient's perspective. (2006) (0)
- Nerve-sparing radical prostatectomy (2007) (0)
- Seven habits of highly effective doctors (2016) (0)
- Screening for prostate cancer. (1994) (0)
- Turning back the tide of litigation (2013) (0)
- Men and their lifestyle (2009) (0)
- Pharmacology and Pathology of the Lower Urinary Tract I. Benign Prostatic Hyperplasia (BPH) (1999) (0)
- An update on the use of 5α-reductase inhibitors (2004) (0)
- Obesity management: lifestyle modification, diet and surgery (2011) (0)
- A journey through your prostate. (2002) (0)
- 1504: Molecular Diagnosis and Staging of Prostate Cancer Using Clusterin in Real Time Reverse Transcription Polymerase Chain Reaction (RT-PCR) (2006) (0)
- Identifying and calling out ‘rogue doctors’ (2020) (0)
- Building personal resilience as a clinician and educator (2019) (0)
- Recommended drug treatment of BPH in primary care (2008) (0)
- Professor John M. Fitzpatrick 1948-2014: a life in the fast lane. (2014) (0)
- Fathers and sons (0)
- The significance of a positive urethral margin at radical prostatectomy (2003) (0)
- Care of the traveller. (2004) (0)
- Comprar Radical Prostatectomy: Principles and Practice | Roger S. Kirby | 9781841846279 | Informa Healthcare (2007) (0)
- 2020: an anniversary year for urology (2019) (0)
- Does inflammation reduce the risk of prostate cancer? (2013) (0)
- Who's up for early detection? (2013) (0)
- A randomised, double-blind, crossover study of doxazosin GITS and tamsulosin in patients with benign prostatic hyperplasia (2002) (0)
- Trends in the Diagnosis and Management of Benign Hyperplasia Prostate in Indonesia (2011) (0)
- Dying to make an impact (2015) (0)
- Authors' reply (1996) (0)
- Learning the lessons from 1000 robot‐assisted radical prostatectomy procedures (2013) (0)
- Patient Pictures: Prostate diseases and their treatments: Clinical drawings for your patients (2010) (0)
- Changing times for the management of localised prostate cancer (2008) (0)
- Happy first anniversary, Trends (2011) (0)
- Prostate cancer screening and treatment (2017) (0)
- Prostate cancer and epidermal growth factor receptors (1990) (0)
- Pharmacological risk factors for altered male sexual function (2008) (0)
- Pharmacotherapy in the Management of Prostate Cancer (2008) (0)
- TRADING PLACES : IBIS AIDS FLIGHTS OVERSEAS (1996) (0)
- 1700: Efficacy of Extended-Release Doxazosin and Standard Doxazosin in Patients with Concomitant Benign Prostatic Hyperplasia and Sexual Dysfunction (2005) (0)
- Radical prostatectomy – making the transition from open to robotic surgery: the London experience (2007) (0)
- 92 Prevalence of ejaculatory disorders and their bothersomeness in the ageing male: Association with LUTS severity and the IPSS bother score (2004) (0)
- IL-1 The Development of Robot Assisted Laparoscopic Prostatectomy (RALP) : Making the Transition from Open Retropubic Prostatectomy (RP) to RALP (2007) (0)
- Charity begins at home (2012) (0)
- Erectile dysfunction: cardiovascular risk and the primary care clinician. (2009) (0)
- The Internet for British Urologists. (1997) (0)
- Treatment options for localized prostate cancer (2008) (0)
- Comprar ABC Of Prostate Cancer | Dasgupta, Prokar | 9781444334371 | Wiley (2011) (0)
- First word: nudging men towards better health (2011) (0)
- Suicide gene therapy in the rat model of prostate cancer (1999) (0)
- THE TROUBLE WITH MEN (2012) (0)
- European Association of Urology (eau): 12th Congress, Paris, September 1996: Abstracts (1996) (0)
- First word: patient safety matters (2011) (0)
This paper list is powered by the following services:
